Gilead raised its previous guidance of $800 million in revenues from the long-acting PrEP injectable Yeztugo based on a ...

Gilead stock fell early Friday as investors digested a first-quarter report driven by Descovy, rather than Yeztugo.

Sarah Rutstein, MD, PhD, and Thibaut Davy‑Mendez, PhD, MSPH, with the Institute for Global Health and Infectious Diseases have received an R01 from the National Institute of Mental Health (NIMH) at ...

Gilead’s Tomas Cihlar and his team of researchers have spent decades studying HIV—and their latest innovation could be a game changer for prevention.

Once trapped in a cycle of addiction and instability, Lakshminarayana Narasappa has spent the last 25 years building ...

One person, who regularly collects methadone weekly from TB HIV Care's drop-off centre in Cape Town, says he has been turned away several times without any medication or only enough for a couple of ...

One person, who regularly collects methadone weekly from TB HIV Care’s drop-off centre in Cape Town, says he has been turned ...

Duke has won federal funding to lead a national HIV vaccine research consortium since 2005. Now the National Institutes of Health is ending its grant.

NOTE: This article is carved from a speech delivered by the author on the occasion of A Freshers Welcome program organized by the Agriculture Science Department of Fumbisi Senior High School in ...

Adam Hall, of Tyne and Wear, will serve at least 23 years in prison, with victims describing lasting trauma A “callous, calculating sexual predator” who raped and deliberately infected young, ...

Prism Health North Texas was one of 32 sites to enroll patients in the global clinical trial for Idvynso. The U.S. Food and Drug Administration approved the treatment for people living with HIV ...